Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

Launched by VASTRA GOTALAND REGION · Jun 4, 2025

Keywords

ClinConnect Summary

This clinical trial is testing a new treatment involving dry plasma to help patients who are experiencing severe bleeding before they reach the hospital. The main goal is to see if using dry plasma can improve survival rates and reduce complications for patients who are at risk of going into shock from heavy bleeding. Researchers will compare the effects of dry plasma with the standard treatment, which is a type of fluid called crystalloid, to find out which one is more effective in saving lives.

To be part of this study, participants need to be adults aged 18 and older who show clear signs of major bleeding, estimated to be over 500 milliliters. Unfortunately, those under 18 or without signs of significant bleeding cannot participate. If eligible, participants can expect to receive either the dry plasma or the standard treatment during their medical emergency. This trial is important as it may lead to better outcomes for patients suffering from life-threatening bleeding.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with clinical signs of bleeding. The bleeding is estimated by the ambulance personnel as being \> 500mL.
• Exclusion Criteria:
• • Patients \< 18 years of age.
• • Patients who lack clinical signs of major bleeding.